The Big Deal: Invest in Acquire
This investment opportunity offers exposure to a fintech company addressing a significant pain point in the rapidly growing private and alternative investment markets.
November 26, 2024
This investment opportunity offers exposure to a fintech company addressing a significant pain point in the rapidly growing private and alternative investment markets.
I’m pleased to announce we’ve negotiated a special valuation for the investment in Acquire’s bridge round. I can’t mention it publicly, but the rack rate, $10 million, was already pretty attractive.
This is a special deal for us. Through Altea, we’re a pilot program user of Acquire’s Invest I.Q. Platform, and I’ve had the good fortune to work closely with CEO Brian Harstine and his team.
Today, we’re talking about a company serving a massive demographic that no one is talking about.
This is a company we’ve talked about before, and they’re back for another round.
Today, we’re looking at options (get it) to hedge against a market correction in 2024.
We’ve got a strategy to play on two different theses that might become reality in 2024. If either thesis hits, we win. If they both hit, we win big.
This month, we’re looking at Oberit, an early-stage HealthTech company that’s advancing the mental health and addiction recovery category with AI-powered, incentive-based behavioral change.
This month, we’re looking at a company making parents’ lives easier by taking the hassle out of travelling with little ones.
Today, we’re looking at something completely different – it’s an FMCG brand called selfmade, and they’re pioneering the field of psychodermatology.
Today’s version of the Big Deal features two opportunities, but they’re only available to accredited investors and qualified purchasers.
This month, we’re looking at something completely different – it’s an FMCG brand called AKUA, and they’re introducing the west to something the east has known about for centuries — kelp-based food.
We create indices for eclectic modern alts. We’ve got a vinyl index, a whiskey index, and more. This helps us find the best buying opportunities for our alternative investment fund
We wrap everything up with a rich qualitative analysis. You’ll understand the pros & cons of investing in all sorts of alternative asset classes.
Disclaimer: The authors of Alt Assets, Inc. are not finance or tax professionals. They are self-taught accredited investors, sharing information, research, and lessons learned. The published content is unique, based on certain assumptions and market conditions at the time of publishing and is intended to serve solely as research, not financial advice. Alts I LLC (the “Fund”) is an affiliate of Alt Assets, Inc. and the Fund has conducted a private placement offering under Rule 506(c) of Regulation D of the Securities Act of 1933, as amended. The Fund may invest in one, several or all of the alternative asset classes that Alt Assets, Inc. publishes content on its site. Any published articles on Alt Assets, Inc. that an alternative asset has a “buy”, “pass”, “overvalued” or “undervalued” designation does not factor into the asset classes that the Fund through its manager ultimately invests in, and thus, any of the Fund’s investments that have positive designations on the Alt Assets, Inc.’s site are purely coincidental as the Fund is actively managed and guided by its own investment parameters as summarized in the relevant private placement memorandum.